After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Fulcrum Therapeutics Inc is $715.12M. A total of 0.56 million shares were traded on the day, compared to an average of 1.30M shares.
In the most recent transaction, Oltmans Curtis Gale sold 3,452 shares of FULC for 12.92 per share on Dec 15 ’25. After the transaction, the Chief Legal Officer now owns 10,252 company shares. In a previous transaction on Dec 15 ’25, CURTIS G OLTMANS bought 3,452 shares at 13.00 per share.
Among the insiders who sold shares, RA CAPITAL MANAGEMENT, L.P. disposed of 4,175,139 shares on Dec 08 ’25 at a per-share price of $13.98. This resulted in the 10% Owner holding 6,053,960 shares of FULC after the transaction. In another insider transaction, RA Capital Healthcare Fund LP bought 4,175,139 shares at $12.99 per share on Dec 08 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, FULC has a high of $15.74 and a low of $2.32.
As of this writing, FULC has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.26 per share and a lower estimate of -$0.33. The company reported an EPS of -$0.31 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. FULC’s latest balance sheet shows that the firm has $218.16M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $19.20M in liabilities at the time. Its Book Value Per Share was $3.67, while its Total Shareholder’s Equity was $211.54M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FULC is Buy with a score of 4.30.
